Clinical Trial Update: Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients? [NA]

View source ↗

Summary

A clinical trial is evaluating external vagus nerve stimulation to reduce systemic inflammatory mediators in Duchenne muscular dystrophy; enrollment is by invit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• External vagus nerve stimulation (taVNS) device

Snippet

Sponsor: taVNS AB | Conditions: Duchenne Muscular Dystrophy (DMD) | NA | Status: ENROLLING_BY_INVITATION